MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$1,205,312
EPS
-$0.14
Unit: Dollar

Income Statement
2026-06-30
2026-03-31
2025-12-31
Research and development
138,167 165,577 443,541.5*
General and administrative
1,062,449 978,576 910,194.25*
Total operating expenses
1,200,616 1,144,153 1,353,735.75
Loss from operations
-1,200,616 -1,144,153 -1,353,735.75*
Interest expense
4,696 1,943 18,164.75*
Loss on change in fair value of derivative liabilities
---1,578*
Loss (gain) on extinguishment of debt
--81,586.25*
Total other expense (income), net
-4,696 -1,943 61,843.5*
Loss before provision for income taxes
-1,205,312 -1,146,096 -1,291,892.25
Net loss
-1,205,312 -1,146,096 -1,291,892.25
Basic EPS
-0.14 -0.13 -0.165
Diluted EPS
-0.14 0.13 -0.165
Basic Average Shares
8,849,266 8,701,837 7,812,264
Diluted Average Shares
8,849,266 8,701,837 7,812,264
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$1,205,312 Loss beforeprovision for income taxes-$1,205,312 Loss from operations-$1,200,616 Total other expense(income), net-$4,696 Total operatingexpenses$1,200,616 Interest expense$4,696 General andadministrative$1,062,449 Research and development$138,167

ADAPTIN BIO, INC. (APTN)

ADAPTIN BIO, INC. (APTN)